Your browser is no longer supported. Please, upgrade your browser.
MNTA Momenta Pharmaceuticals, Inc. daily Stock Chart
MNTA [NASD]
Momenta Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-2.92 Insider Own0.30% Shs Outstand117.61M Perf Week-9.37%
Market Cap2.84B Forward P/E- EPS next Y-2.03 Insider Trans-73.31% Shs Float113.29M Perf Month-24.05%
Income-290.10M PEG- EPS next Q-0.48 Inst Own- Short Float3.02% Perf Quarter27.52%
Sales23.90M P/S119.04 EPS this Y-29.10% Inst Trans0.13% Short Ratio2.58 Perf Half Y88.69%
Book/sh4.46 P/B5.42 EPS next Y-3.60% ROA-56.50% Target Price37.38 Perf Year76.96%
Cash/sh4.43 P/C5.45 EPS next 5Y- ROE-79.20% 52W Range9.51 - 34.83 Perf YTD22.61%
Dividend- P/FCF- EPS past 5Y-8.90% ROI-65.60% 52W High-30.55% Beta1.58
Dividend %- Quick Ratio5.10 Sales past 5Y-14.50% Gross Margin- 52W Low154.36% ATR3.05
Employees118 Current Ratio5.10 Sales Q/Q-80.80% Oper. Margin- RSI (14)43.19 Volatility9.17% 12.98%
OptionableYes Debt/Eq0.00 EPS Q/Q-748.00% Profit Margin- Rel Volume0.51 Prev Close24.26
ShortableYes LT Debt/Eq0.00 EarningsFeb 26 BMO Payout- Avg Volume1.33M Price24.19
Recom2.30 SMA20-7.22% SMA50-16.46% SMA20031.85% Volume675,297 Change-0.29%
Mar-12-20Initiated Goldman Neutral $29
Jan-15-20Upgrade JP Morgan Neutral → Overweight $30
Nov-12-19Initiated SunTrust Buy $29
Nov-06-19Initiated Wells Fargo Outperform
Sep-25-19Initiated H.C. Wainwright Buy $24
Jan-04-19Downgrade JP Morgan Overweight → Neutral
Nov-05-18Initiated Piper Jaffray Overweight
Feb-22-18Upgrade Stifel Hold → Buy $18 → $21
Oct-05-17Downgrade Stifel Buy → Hold $22 → $15
Sep-28-17Initiated Goldman Neutral $18
May-22-17Downgrade Barclays Overweight → Equal Weight $20 → $17
Feb-22-17Downgrade Leerink Partners Outperform → Mkt Perform
Jan-31-17Reiterated Barclays Overweight $19 → $20
Nov-22-16Initiated Aegis Capital Hold
Oct-11-16Upgrade Barclays Equal Weight → Overweight $13 → $19
Sep-07-16Downgrade Maxim Group Hold → Sell $6
Jun-06-16Initiated Goldman Neutral $14
Jan-08-16Upgrade Maxim Group Sell → Hold
Nov-13-15Initiated JP Morgan Overweight
Aug-06-15Downgrade Goldman Buy → Neutral
Apr-02-20 07:30AM  Momenta Provides Corporate Update Amid COVID-19 Pandemic GlobeNewswire
Mar-30-20 11:12PM  Edited Transcript of MNTA earnings conference call or presentation 26-Feb-20 1:30pm GMT Thomson Reuters StreetEvents +7.68%
Mar-27-20 11:30AM  Momenta (MNTA) Down 0.3% Since Last Earnings Report: Can It Rebound? Zacks -5.72%
Mar-17-20 02:04PM  Top Pharmaceutical Stocks for Q2 2020 Investopedia +10.93%
Feb-28-20 08:54AM  US$37.90 - That's What Analysts Think Momenta Pharmaceuticals, Inc. Is Worth After These Results Simply Wall St.
Feb-27-20 03:08PM  Momenta's (MNTA) Q4 Loss Wider than Expected, Sales Beat Zacks -7.62%
Feb-26-20 08:45AM  Momenta Pharmaceuticals (MNTA) Reports Q4 Loss, Tops Revenue Estimates Zacks
07:00AM  Momenta Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results GlobeNewswire
Feb-19-20 12:31PM  Analysts Estimate Momenta Pharmaceuticals (MNTA) to Report a Decline in Earnings: What to Look Out for Zacks
08:00AM  Momenta Pharmaceuticals to Webcast Presentation at the Cowen 40th Annual Health Care Conference GlobeNewswire
Feb-12-20 10:55AM  Small-Cap Healthcare ETF Outperforming in 2020: 5 Top Stocks Zacks
08:00AM  Momenta Pharmaceuticals Announces Date of Fourth Quarter and Year End 2019 Financial Results Conference Call and Webcast GlobeNewswire
Feb-07-20 11:25AM  What You Must Know About Momenta Pharmaceuticals, Inc.'s (NASDAQ:MNTA) Beta Value Simply Wall St.
Jan-23-20 10:14AM  Can The Uptrend Continue for Momenta Pharmaceuticals? Zacks
Jan-21-20 06:21PM  Novartis (NVS) Gets Approval for MS Drug Mayzent in Europe Zacks -5.65%
Jan-15-20 08:22AM  Momenta (MNTA) Provides Pipeline Updates, Stock Rallies Zacks +13.96%
06:08AM  Momenta Rockets After Analysts Get Bullish on Biopharma's Newest Treatment TheStreet.com
Jan-13-20 07:10AM  Momenta Provides Year-End 2019 Update and 2020 Outlook GlobeNewswire +8.12%
Jan-03-20 08:05AM  Momenta Pharmaceuticals Announces CFO Transition GlobeNewswire
Dec-24-19 08:00AM  Momenta Pharmaceuticals to Webcast Presentation at the 38th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-13-19 08:33AM  Momenta Pharmaceuticals (MNTA) Catches Eye: Stock Jumps 7.1% Zacks
08:00AM  Momenta Pharmaceuticals Appoints Dr. Jane F. Barlow to Board of Directors GlobeNewswire
Dec-12-19 08:00AM  Momenta Pharmaceuticals Announces Pricing of Public Offering of Common Stock GlobeNewswire +7.13%
Dec-11-19 07:21AM  The Daily Biotech Pulse: Correvio Faces FDA Panel Rejection, Iterum's Antibiotic Trial Narrowly Misses Primary Endpoint Benzinga -13.06%
Dec-10-19 08:05PM  Did Hedge Funds Drop The Ball On Momenta Pharmaceuticals, Inc. (MNTA) ? Insider Monkey
04:04PM  Momenta Pharmaceuticals Announces Proposed Public Offering of Common Stock GlobeNewswire
Nov-18-19 02:44PM  Edited Transcript of MNTA earnings conference call or presentation 31-Oct-19 12:30pm GMT Thomson Reuters StreetEvents
Nov-10-19 09:02AM  Trade Alert: The Chief Medical Officer & Senior VP of Development Of Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), Santiago Arroyo, Has Sold Some Shares Recently Simply Wall St.
Nov-07-19 08:00AM  Momenta Pharmaceuticals Announces Poster Presentation at the 61st American Society of Hematology Annual Meeting and Exposition GlobeNewswire
Nov-06-19 08:00AM  Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences GlobeNewswire +6.25%
Oct-31-19 09:45AM  Momenta Pharmaceuticals (MNTA) Reports Q3 Loss, Tops Revenue Estimates Zacks
07:00AM  Momenta Pharmaceuticals Reports Third Quarter 2019 Financial and Operating Results GlobeNewswire
Oct-27-19 02:01PM  Is Momenta Pharmaceuticals, Inc. (MNTA) A Good Stock To Buy? Insider Monkey
Oct-24-19 10:32AM  Momenta Pharmaceuticals (MNTA) Expected to Beat Earnings Estimates: Should You Buy? Zacks
Oct-17-19 08:00AM  Momenta Pharmaceuticals Announces Date of Third Quarter 2019 Financial Results Conference Call and Webcast GlobeNewswire
Sep-19-19 08:00AM  Momenta Pharmaceuticals Appoints Dr. Donna Grogan to Board of Directors GlobeNewswire
Sep-16-19 01:32PM  Is Momenta Pharmaceuticals, Inc.'s (NASDAQ:MNTA) CEO Paid At A Competitive Rate? Simply Wall St.
Sep-01-19 09:30AM  Momenta (MNTA) Up 10% Since Last Earnings Report: Can It Continue? Zacks
Aug-08-19 03:45PM  Momenta Continues Its Transition Motley Fool
07:17AM  Edited Transcript of MNTA earnings conference call or presentation 2-Aug-19 12:30pm GMT Thomson Reuters StreetEvents
Aug-05-19 04:35PM  Momenta Pharmaceuticals Inc (MNTA) Q2 2019 Earnings Call Transcript Motley Fool
10:59AM  Momenta (MNTA) Q2 Loss Wider Than Expected, Revenues Miss Zacks
Aug-02-19 08:25AM  Momenta Pharmaceuticals (MNTA) Reports Q2 Loss, Misses Revenue Estimates Zacks
07:00AM  Momenta Pharmaceuticals Reports Second Quarter 2019 Financial and Operating Results GlobeNewswire
Aug-01-19 04:05PM  Momenta Pharmaceuticals Launches Phase 2/3 Trial of M281 for the Treatment of Warm Autoimmune Hemolytic Anemia and is Granted FDA Fast Track Designation GlobeNewswire
Jul-30-19 07:00AM  Momenta Pharmaceuticals Announces Fast Track Designation for M281 (nipocalimab) in Hemolytic Disease of the Fetus and Newborn (HDFN) GlobeNewswire +5.83%
Jul-26-19 10:30AM  Momenta Pharmaceuticals (MNTA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Jul-19-19 08:00AM  Momenta Pharmaceuticals Announces Date of Second Quarter 2019 Financial Results Conference Call and Webcast GlobeNewswire -5.42%
Jun-19-19 08:00AM  Momenta Pharmaceuticals Announces Settlement Agreement with Amphastar Resolving Enoxaparin Sodium Injection Litigation GlobeNewswire
Jun-17-19 03:54PM  Did You Manage To Avoid Momenta Pharmaceuticals's (NASDAQ:MNTA) 47% Share Price Drop? Simply Wall St. +5.18%
Jun-04-19 07:30AM  Momenta Pharmaceuticals to Webcast Presentation at the Goldman Sachs 40th Annual Global Healthcare Conference GlobeNewswire
Jun-01-19 09:31AM  Momenta (MNTA) Down 16.6% Since Last Earnings Report: Can It Rebound? Zacks
May-28-19 03:39PM  Edited Transcript of MNTA earnings conference call or presentation 2-May-19 12:30pm GMT Thomson Reuters StreetEvents
May-09-19 08:00AM  Momenta Pharmaceuticals to Webcast Presentation at the 2019 Bank of America Merrill Lynch Healthcare Conference GlobeNewswire
May-07-19 03:41PM  Momenta Pharmaceuticals Wants to Be the "Humira of the FcRn Space" Motley Fool -8.60%
May-03-19 08:26PM  Hedge Funds Have Never Been This Bullish On Momenta Pharmaceuticals, Inc. (MNTA) Insider Monkey
May-02-19 03:16PM  Momenta Pharmaceuticals Inc (MNTA) Q1 2019 Earnings Call Transcript Motley Fool
10:05AM  Momenta Pharmaceuticals (MNTA) Reports Q1 Loss, Misses Revenue Estimates Zacks
09:01AM  Momenta: 1Q Earnings Snapshot Associated Press
07:00AM  Momenta Pharmaceuticals Reports First Quarter 2019 Financial and Operating Results GlobeNewswire
Apr-25-19 10:33AM  Momenta Pharmaceuticals (MNTA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Apr-18-19 08:00AM  Momenta Pharmaceuticals Announces Date of First Quarter 2019 Financial Results Conference Call and Webcast GlobeNewswire
Mar-29-19 07:35AM  New Research Coverage Highlights American International Group, Fox Factory Holding, Momenta Pharmaceuticals, Mercer International, Endurance International Group, and Addus HomeCare Consolidated Revenues, Company Growth, and Expectations for 2019 GlobeNewswire
Mar-28-19 07:00AM  Momenta Pharmaceuticals Announces Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2019 GlobeNewswire
Mar-27-19 06:13PM  Novartis (NVS) Receives FDA Approval for MS Drug Mayzent Zacks
Mar-24-19 09:30AM  Momenta (MNTA) Down 6.8% Since Last Earnings Report: Can It Rebound? Zacks
Mar-21-19 08:43AM  Momenta Pharmaceuticals Announces Publication of New Data Supporting M281 as First Anti-FcRn Antibody to Inhibit Maternal-Fetal IgG Transfer in the Human Term Placenta GlobeNewswire
Mar-12-19 11:38AM  How Should Investors React To Momenta Pharmaceuticals, Inc.s (NASDAQ:MNTA) CEO Pay? Simply Wall St.
Mar-01-19 06:38AM  Edited Transcript of MNTA earnings conference call or presentation 22-Feb-19 1:30pm GMT Thomson Reuters StreetEvents
Feb-28-19 02:01PM  Momenta Continues to Rebuild Motley Fool
Feb-25-19 10:28AM  Momenta (MNTA) Q4 Loss Narrower Than Expected, Revenues Beat Zacks
Feb-22-19 10:05AM  Momenta Pharmaceuticals (MNTA) Reports Q4 Loss, Tops Revenue Estimates Zacks +8.55%
06:47AM  Momenta: 4Q Earnings Snapshot Associated Press
06:30AM  Momenta Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results GlobeNewswire
Feb-15-19 10:30AM  Analysts Estimate Momenta Pharmaceuticals (MNTA) to Report a Decline in Earnings: What to Look Out for Zacks +8.92%
Feb-08-19 08:00AM  Momenta Pharmaceuticals Announces Date of Fourth Quarter and Year End 2018 Financial Results Conference Call and Webcast GlobeNewswire +5.81%
Feb-07-19 08:00AM  Momenta Pharmaceuticals Announces Oral Presentation of New Data for M281 at the Society for Maternal-Fetal Medicine 2019 Annual Meeting GlobeNewswire
Jan-29-19 08:00AM  Momenta Pharmaceuticals Announces First Subject Dosed in Phase 1/2 Clinical Trial of M254, Hypersialylated Immunoglobulin G GlobeNewswire
Jan-23-19 07:55AM  New Research Coverage Highlights Lennox International, Momenta Pharmaceuticals, Westlake Chemical Partners LP, Symantec, American Eagle Outfitters, and FTD Companies Consolidated Revenues, Company Growth, and Expectations for 2019 GlobeNewswire
Jan-07-19 01:46PM  What Investors Should Know About Momenta Pharmaceuticals, Inc.s (NASDAQ:MNTA) Financial Strength Simply Wall St. +7.83%
Jan-02-19 08:00AM  Momenta Pharmaceuticals to Webcast Presentation at the 37th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-17-18 09:41PM  Here is What Hedge Funds Think About Momenta Pharmaceuticals, Inc. (MNTA) Insider Monkey
12:38PM  Edited Transcript of MNTA earnings conference call or presentation 7-Nov-18 1:00pm GMT Thomson Reuters StreetEvents
Dec-11-18 05:06PM  Here's Why Momenta Pharmaceuticals Fell for a Second Straight Day Motley Fool -10.39%
04:05PM  Momenta Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares GlobeNewswire
03:03PM  Teva (TEVA) Stock Poised to Record Big Gains in 2019? Zacks
Dec-07-18 04:23PM  Here's Why Momenta Pharmaceuticals Jumped 18% on Friday Motley Fool +17.96%
08:04AM  The Daily Biotech Pulse: FDA Nod For Roche, Bristol-Myers Hikes Dividend, 2 Biotechs To Debut Benzinga
Dec-06-18 08:13PM  Momenta Pharmaceuticals Announces Pricing of Public Offering of Common Stock GlobeNewswire +8.15%
07:56AM  The Daily Biotech Pulse: AbbVie Halts Lung Cancer Trial, Oncomed Merges With Mereo, Momenta Offering Benzinga
Dec-05-18 04:15PM  Momenta Pharmaceuticals Announces Proposed Public Offering of Common Stock GlobeNewswire
Dec-03-18 04:05PM  Momenta Pharmaceuticals Provides Update on US Regulatory Strategy for M923, Proposed Biosimilar to HUMIRA® GlobeNewswire
Nov-27-18 07:30AM  Factors of Influence in 2018, Key Indicators and Opportunity within Eclipse Resources, DISH Network, Navigant Consulting, TreeHouse Foods, Momenta Pharmaceuticals, and Party City Holdco New Research Emphasizes Economic Growth GlobeNewswire
Nov-17-18 08:36AM  Why Abbvie Is Down 5% in 2018 So Far Motley Fool
Nov-16-18 02:06PM  Momenta Moves On Motley Fool
Nov-09-18 03:25PM  Momenta (MNTA) Reports Narrower-Than-Expected Loss in Q3 Zacks -9.55%
Nov-07-18 12:30PM  Momenta Pharmaceuticals Inc (MNTA) Q3 2018 Earnings Conference Call Transcript Motley Fool
09:45AM  Momenta Pharmaceuticals Announces Publication of Phase 1 Study Data for Anti-FcRn Antibody, M281 GlobeNewswire
07:50AM  The Daily Biotech Pulse: FDA Nod For Bristol-Myers Squibb, Momenta Strikes Patent License Deal With AbbVie Benzinga
07:40AM  Momenta Pharmaceuticals (MNTA) Reports Q3 Loss, Lags Revenue Estimates Zacks
Momenta Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases in the United States. Its novel therapeutic programs include M281, a fully-human anti-neonatal Fc receptor (FcRn), aglycosylated immunoglobulin G (IgG1), and monoclonal antibody to reduce circulating IgG antibodies by blocking endogenous IgG recycling via FcRn; M230, a recombinant trivalent human IgG1 Fc multimer containing three IgG Fc regions joined to maximize activity; and M254, a hyper-sialylated immunoglobulin to treat various inflammatory diseases, including idiopathic thrombocytopenic purpura and chronic inflammatory demyelinating polyneuropathy. The company's biosimilar programs comprise M923, a biosimilar of HUMIRA for the treatment of patients with rheumatoid arthritis, crohn's disease, ulcerative colitis, and psoriasis; and M710, a biosimilar of EYLEA for the treatment of neovascular age-related macular degeneration, macular edema following retinal vein occlusion, diabetic macular edema (DME), and diabetic retinopathy in patients with DME. Its complex generics programs include Enoxaparin sodium injection, a generic version of LOVENOX that is indicated for the prevention and treatment of deep vein thrombosis, as well as supports the treatment of acute coronary syndromes; GLATOPA, a generic version of once-daily COPAXONE for the treatment of patients with relapsing forms of multiple sclerosis; and GLATOPA, a generic version of three-times-weekly COPAXONE. The company has collaboration and license agreements with Sandoz AG, Mylan Ireland Limited, and CSL Behring Recombinant Facility AG. The company was formerly known as Mimeon, Inc. and changed its name to Momenta Pharmaceuticals, Inc. in September 2002. Momenta Pharmaceuticals, Inc. was founded in 2001 and is headquartered in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WHEELER CRAIG APresident & CEOMar 10Sale28.753479,97654,664Mar 10 04:43 PM
WHEELER CRAIG APresident & CEOMar 06Sale28.5137,2281,061,37055,011Mar 09 05:27 PM
KWON YOUNGChief Financial & Bus. OfficerMar 06Sale28.967,356213,030138,836Mar 09 05:17 PM
Manning Anthony M.Chief Scientific OfficerMar 06Sale29.007,310211,99012,758Mar 09 05:15 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerMar 06Sale29.007,310211,99050,515Mar 09 05:16 PM
FIER IANChief Mfg and Program OfficerMar 06Sale29.007,310211,9907,690Mar 09 05:14 PM
Carvajal AlejandraChief Legal OfficerMar 06Sale29.005,302153,7589,698Mar 09 05:14 PM
Arroyo SantiagoSVP, Chief Medical OfficerMar 06Sale28.977,356213,10327,220Mar 09 05:12 PM
FIER IANChief Mfg and Program OfficerFeb 20Option Exercise13.853,78852,45315,931Feb 24 07:26 PM
FIER IANChief Mfg and Program OfficerFeb 20Sale33.3715,931531,5710Feb 24 07:26 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerFeb 19Sale33.4559119,76942,825Feb 20 05:06 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerFeb 18Sale32.8913,750452,23843,416Feb 20 05:06 PM
Manning Anthony M.Chief Scientific OfficerFeb 18Sale32.5616,459535,9055,068Feb 20 05:06 PM
WHEELER CRAIG APresident & CEOFeb 14Option Exercise13.2621,894290,31439,372Feb 19 06:42 PM
Carvajal AlejandraChief Legal OfficerFeb 14Sale31.546,892217,3740Feb 19 06:43 PM
WHEELER CRAIG APresident & CEOFeb 14Sale32.0021,894700,60817,478Feb 19 06:42 PM
FIER IANChief Mfg and Program OfficerFeb 13Sale30.036,689200,87112,143Feb 14 06:53 PM
Carvajal AlejandraChief Legal OfficerFeb 13Sale30.033,10893,3336,892Feb 14 06:52 PM
KWON YOUNGChief Financial & Bus. OfficerFeb 13Sale30.039,016270,750130,103Feb 14 06:54 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerFeb 13Sale30.0313,356401,10857,166Feb 14 06:55 PM
WHEELER CRAIG APresident & CEOFeb 13Sale30.822,77885,61817,478Feb 14 06:53 PM
Arroyo SantiagoSVP, Chief Medical OfficerFeb 13Sale30.037,689230,90119,576Feb 14 06:55 PM
Manning Anthony M.Chief Scientific OfficerFeb 13Sale30.038,541256,48622,316Feb 14 06:54 PM
WHEELER CRAIG APresident & CEOFeb 12Option Exercise13.264,58160,74418,665Feb 14 06:53 PM
Manning Anthony M.Chief Scientific OfficerFeb 12Sale31.6378924,95621,527Feb 14 06:54 PM
WHEELER CRAIG APresident & CEOFeb 12Sale32.014,581146,63814,084Feb 14 06:53 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerFeb 11Option Exercise12.7625,000319,00070,913Feb 12 05:29 PM
WHEELER CRAIG APresident & CEOFeb 11Option Exercise13.2635,302468,10551,159Feb 12 06:00 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerFeb 11Sale31.5125,528804,26743,022Feb 12 05:29 PM
WHEELER CRAIG APresident & CEOFeb 11Sale32.0937,0751,189,73514,084Feb 12 06:00 PM
Manning Anthony M.Chief Scientific OfficerFeb 11Sale32.231123,6105,857Feb 12 05:28 PM
KWON YOUNGChief Financial & Bus. OfficerFeb 11Sale32.2335011,281111,619Feb 12 05:27 PM
FIER IANChief Mfg and Program OfficerFeb 11Sale32.2335011,2811,332Feb 12 05:28 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerFeb 10Option Exercise10.832,36325,59145,913Feb 12 05:29 PM
FIER IANChief Mfg and Program OfficerFeb 10Sale31.502136,7101,682Feb 11 07:04 PM
KWON YOUNGChief Financial & Bus. OfficerFeb 10Sale31.5040812,852111,969Feb 11 07:02 PM
WHEELER CRAIG APresident & CEOFeb 10Sale31.432,60181,74915,857Feb 11 07:03 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerFeb 10Sale31.5060519,05843,550Feb 11 07:03 PM
Manning Anthony M.Chief Scientific OfficerFeb 10Sale31.502247,0565,969Feb 11 07:01 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerFeb 10Sale31.002,36373,25368,550Feb 12 05:29 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerFeb 07Option Exercise18.852,69150,72545,501Feb 11 07:03 PM
WHEELER CRAIG APresident & CEOFeb 07Option Exercise13.264,89064,84117,567Feb 11 07:03 PM
WHEELER CRAIG APresident & CEOFeb 07Sale32.044,890156,67612,677Feb 11 07:03 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerFeb 07Sale31.062,69183,58244,155Feb 11 07:03 PM
WHEELER CRAIG APresident & CEOFeb 05Option Exercise13.2612,229162,15724,906Feb 07 05:19 PM
WHEELER CRAIG APresident & CEOFeb 05Sale30.2112,229369,43812,677Feb 07 05:19 PM
WHEELER CRAIG APresident & CEOFeb 04Option Exercise13.2615,505205,59628,182Feb 05 05:19 PM
WHEELER CRAIG APresident & CEOFeb 04Sale30.0415,505465,77012,677Feb 05 05:19 PM
WHEELER CRAIG APresident & CEOFeb 03Option Exercise13.265,59974,24318,276Feb 05 05:19 PM
WHEELER CRAIG APresident & CEOFeb 03Sale30.025,599168,08212,677Feb 05 05:19 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerJan 24Sale28.191,21934,36442,810Jan 27 05:49 PM
FIER IANChief Mfg and Program OfficerJan 22Sale28.981,57745,7011,182Jan 24 04:41 PM
Carvajal AlejandraChief Legal OfficerJan 22Sale28.981,57745,7010Jan 24 04:41 PM
Manning Anthony M.Chief Scientific OfficerJan 22Sale29.012,26565,7105,443Jan 24 04:40 PM
KWON YOUNGChief Financial & Bus. OfficerJan 21Sale30.081,23537,149110,968Jan 22 05:13 PM
Arroyo SantiagoSVP, Chief Medical OfficerJan 21Sale30.081,23537,1492,265Jan 22 05:15 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerJan 21Sale30.0886025,86944,029Jan 22 05:15 PM
Manning Anthony M.Chief Scientific OfficerJan 21Sale30.081,23537,1497,708Jan 22 05:17 PM
Carvajal AlejandraChief Legal OfficerJan 21Sale30.0886025,8691,577Jan 22 05:16 PM
FIER IANChief Mfg and Program OfficerJan 21Sale30.0886025,8692,759Jan 22 05:18 PM
Gutierrez-Ramos Jose-CarlosDirectorJan 21Sale29.1010,090293,5750Jan 23 05:14 PM
Manning Anthony M.Chief Scientific OfficerJan 15Option Exercise18.1929,114529,56234,557Jan 17 04:14 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerJan 15Option Exercise18.0243,194778,15885,646Jan 17 04:15 PM
Manning Anthony M.Chief Scientific OfficerJan 15Sale28.4429,114828,0025,443Jan 17 04:14 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerJan 15Sale28.5843,1941,234,54442,452Jan 17 04:15 PM
FIER IANChief Mfg and Program OfficerJan 14Option Exercise15.6287,7031,370,32288,885Jan 16 05:14 PM
Stoner ElizabethDirectorJan 14Option Exercise13.165,75075,67039,745Jan 16 05:13 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerJan 14Option Exercise13.44121,3251,630,408165,041Jan 16 05:14 PM
FIER IANChief Mfg and Program OfficerJan 14Sale23.5887,7032,068,1471,182Jan 16 05:14 PM
Stoner ElizabethDirectorJan 14Sale25.004,236105,90035,509Jan 16 05:13 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerJan 14Sale23.42122,5892,870,76142,452Jan 16 05:14 PM
FIER IANChief Mfg and Program OfficerDec 24Option Exercise10.8335,437383,78340,315Dec 27 05:00 PM
Manning Anthony M.Chief Scientific OfficerDec 24Option Exercise12.4951,445642,51956,888Dec 27 04:59 PM
Manning Anthony M.Chief Scientific OfficerDec 24Sale20.0051,4451,028,9005,443Dec 27 04:59 PM
FIER IANChief Mfg and Program OfficerDec 24Sale20.0039,133782,6601,182Dec 27 05:00 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerDec 24Sale20.0031,104622,08043,716Dec 27 04:57 PM
WHEELER CRAIG APresident & CEODec 02Option Exercise15.3733,334512,34446,011Dec 03 06:11 PM
WHEELER CRAIG APresident & CEODec 02Sale16.6933,334556,34412,677Dec 03 06:11 PM
WHEELER CRAIG APresident & CEONov 26Option Exercise15.3766,6661,024,65679,343Nov 27 08:41 PM
WHEELER CRAIG APresident & CEONov 26Sale17.0066,6661,133,32212,677Nov 27 08:41 PM
Manning Anthony M.Chief Scientific OfficerNov 13Sale16.5361910,2315,443Nov 14 06:11 PM
WHEELER CRAIG APresident & CEONov 13Sale16.252,77845,14312,677Nov 14 06:10 PM
WHEELER CRAIG APresident & CEONov 12Sale16.491,77229,2209,283Nov 13 05:14 PM
FIER IANChief Mfg and Program OfficerNov 12Sale16.185298,5594,878Nov 13 05:13 PM
KWON YOUNGSVP, Chief Business OfficerNov 12Sale16.185298,559108,703Nov 13 05:12 PM
Manning Anthony M.Chief Scientific OfficerNov 12Sale16.181692,7346,062Nov 13 05:11 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerNov 12Sale16.185298,55974,820Nov 13 05:10 PM
KWON YOUNGSVP, Chief Business OfficerNov 08Sale16.0663210,150109,232Nov 12 04:21 PM
WHEELER CRAIG APresident & CEONov 08Sale16.162,60142,03211,055Nov 12 04:19 PM
FIER IANChief Mfg and Program OfficerNov 08Sale16.063205,1395,407Nov 12 04:23 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerNov 08Sale16.066039,68475,349Nov 12 04:24 PM
Manning Anthony M.Chief Scientific OfficerNov 08Sale16.063375,4126,231Nov 12 04:21 PM
Manning Anthony M.Chief Scientific OfficerNov 07Sale15.968,420134,3835,818Nov 12 04:21 PM
Arroyo SantiagoSVP, Chief Medical OfficerNov 07Sale15.9126,954428,8380Nov 08 04:13 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerOct 29Option Exercise15.3714,781227,18484,565Oct 31 04:33 PM
BELTRAMELLO JO ANNChief HR and Inf. OfficerOct 29Sale15.3814,781227,33274,607Oct 31 04:33 PM
ROBERTSON MICHELLEChief Financial OfficerOct 25Sale15.006,802102,0306,813Oct 29 08:57 PM
Carvajal AlejandraChief Legal OfficerOct 21Sale14.406,81498,1220Oct 23 05:19 PM
FIER IANChief Mfg and Program OfficerOct 21Sale14.405,77083,0885,015Oct 23 05:18 PM
Arroyo SantiagoSVP, Chief Medical OfficerOct 18Sale13.836,31887,37826,954Oct 21 04:29 PM